EF-011

N/A

Report date: 2024/11/21 13:51:09
NME

Base Information

Drug NameEF-011
Drug Alias NameEF-011EF011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscription factor SOX-2 modulators
TargetsTranscription factor SOX-2
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEverfront Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEverfront Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A